APR 15, 2017 06:49 AM PDT

Study IDs MicroRNA as a New Target for Pancreatic Cancer

WRITTEN BY: Xuan Pham

Tiny non-coding RNA molecules may have a role in the progression of pancreatic cancer, one of the most aggressive diseases with high mortality rate. The molecule, known as MIR506, seems to increase the growth of pancreatic tumors through the deregulation of cell death.

MIR506 is a micro RNA. These are short nucleotide sequences, usually 21-23 bases long, and act to silence gene expression. In some human cancers, certain miRNAs are either too overactive or underactive, which can lead to the erroneous overexpression of some cancer pathways. In this case, MIR506 has been implicated to function in several tumors as a tumor suppressor gene or oncogene. Its role in pancreatic cancer is less clear.

Pancreatic cancer is notorious for its lethality. The most common type of pancreatic cancer is known as pancreatic ductal adenocarcinoma (PDAC). It accounts for a small percentage of all diagnosed cancer (around 3 percent), but claims an aggressive number of lives (around 7 percent of all cancer-related deaths in the US). It’s estimated that of the 53,000 Americans who will be diagnosed with pancreatic cancer this year, almost 79 percent will succumb from the disease.

Since MIR506 has been previously linked to tumor suppressor activity in ovarian cancer, scientists from the Wake Forest Baptist Medical Center decided to test whether this molecule acts in similar ways in PDAC.

The team analyzed MIR506 expression in mice with transplanted human pancreatic tumors. "By using an animal model to expand tumor cells recently removed from patients, we hoped to re-create more closely what actually happens in patients with pancreatic cancer rather than by using existing artificial cell lines," said Wei Zhang, the study’s senior investigator.

Compared to healthy cells, pancreatic tumor cells showed lower levels of MIR506. Furthermore, increasing the levels of MIR506 in pancreatic tumors seemed to stunt their ability to metastasize.

The team hypothesized that MIR506 “exerted a tumor suppression function in PDAC by inducing autophagy-related cell death." Autophagy, from the Greek “self-devouring,” is a natural degradation process that allows cells to recycle its components. In pancreatic cancer, low levels of MIR506 may have allowed the tumor cells to escape natural cell death. By contrast, increasing levels of MIR506 in these tumors stripped the cells of their protection and made them vulnerable to autophagy.

"The potential therapeutic value of this finding is important because we could deliver MIR506 directly to pancreatic cancer cells using technologies like nanoparticles and exosomes," Zhang said. "Hopefully, this will provide us with a new way to fight this deadly form of cancer."

Additional sources: Wake Forest Baptist Medical Center, MNT

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
AUG 02, 2018
Genetics & Genomics
AUG 02, 2018
The Genetic Hotspots That Can Lead to Cancer
In some of our body's tissues, cells have to replicate many times. That introduces a chance for new genetic errors every time....
AUG 13, 2018
Videos
AUG 13, 2018
What does sunscreen look like with a UV camera?
  Have you ever wondered if there’s really a difference between SPF 30 and SPF 50? You’re not the only one. YouTuber Physics Girl set out...
AUG 21, 2018
Cancer
AUG 21, 2018
'Zombie' gene returns to life and kills cancer in elephants
Researchers have discovered a gene that can protect elephants from cancer. An estimated 17 percent of humans worldwide die from cancer, but less than five ...
AUG 30, 2018
Genetics & Genomics
AUG 30, 2018
Genetic Changes can Help Diagnose Childhood Cancers Far Earlier
New research has revealed genetic rearrangements that happen far before bone cancer starts growing in children....
SEP 04, 2018
Cancer
SEP 04, 2018
Metal beads that could help reduce chemotherapy side effects in brain tumor
Brain tumors are one of the most challenging types of cancers to treat. Only 1 in 7 patients will survive the disease, and those survivors will usually suffer from lots of side effects becaus...
SEP 05, 2018
Videos
SEP 05, 2018
Why Glioblastoma Is So Deadly
Senator John McCain passed away recently after battling brain cancer. Most forms of brain cancer are aggressive and difficult to treat because medications...
Loading Comments...